---
category: news
title: "Lantern Pharma Reports Second Quarter 2021 Financial Results and Operational Highlights"
excerpt: "Lantern Pharma Inc. (NASDAQ: LTRN) (\"Lantern\"), a clinical stage biopharmaceutical company using its proprietary RADRÂ® artificial intelligence (\"A.I.\") platform to transform oncology drug discovery and development today announced financial results for the second quarter ended June 30,"
publishedDateTime: 2021-07-29T20:16:00Z
originalUrl: "https://markets.businessinsider.com/news/stocks/lantern-pharma-reports-second-quarter-2021-financial-results-and-operational-highlights-1030664246"
webUrl: "https://markets.businessinsider.com/news/stocks/lantern-pharma-reports-second-quarter-2021-financial-results-and-operational-highlights-1030664246"
type: article
quality: 46
heat: 46
published: false

provider:
  name: Business Insider
  domain: businessinsider.com
  images:
    - url: "https://everyday-cc.github.io/ai/assets/images/organizations/businessinsider.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://mma.prnewswire.com/media/1216507/Lantern_Pharma_Logo.jpg"
    width: 400
    height: 296
    isCached: true

secured: "sE7wu9J+f0W1Z7kCv9zqdR5NzccuOE9o5ZaqaEe0lbShLJJQ5X0ALdemFYSJRicppgRa+oaxYNBHOFCeGmpFgZeJ52nB7L44GUvllaxkEmrah2tqBdYZ3JwJ5r+C+Q21o1re2rKPj4xntArKQmhhpJkUUe9JOlPGRCxKA2GPM3oaYHPZfQpwEFpuW1e9xssvT0qRweia115Lt9mWy88TgPTPAJ0vNrI5a6i2nVX6zhNSURjo6uOdxJ/9sm6MMe5nvJxiyh4CgaExk7FEicaOSl4LKYhD1dWAj+uNMZhnO38qsR0p71H7Q3cWytUuLUtVgmtgTPlnl4x7YmP+fHid6JbWqD5CFDrPrxzhnrSRDmo=;4q8a6Zh9hudW0jMNUMjFig=="
---

